• Open-Source Medical Device Platform Aims to Accelerate Time to Market

    Bio-IT World | San Francisco biotech Openwater is pioneering a multi-purpose platform approach to medical device development, combining infrared light and low-intensity focused ultrasound technologies to create what CEO Aaron Timm describes as the "smartphone" of medical devices.

    Aug 14, 2025
  • AI-Powered Cell Mapping Platform Accelerates Biotech Research and Drug Development

    Bio-IT World | Virginia Commonwealth University researchers have developed an artificial intelligence platform that could dramatically accelerate biotech research by solving one of the field's most computationally intensive challenges—rapidly identifying and analyzing distinct cell types in complex biological tissues.

    Aug 13, 2025
  • AI in Medicine Making and Healthcare: Finding the Balance

    Bio-IT World | The pharma industry excels at collaborating with startup companies and scaling up the production of drugs and biologics, but they may be missing the big-picture perspective of the U.S. government as well as some of the cutting-edge research happening within academia. It’s a problematic norm that needs addressing if artificial intelligence (AI) is to benefit drug discovery and diagnostics as well as healthcare delivery in terms of safety, equity, and effectiveness.

    Aug 12, 2025
  • Russia Targets National Database of 1 Million Genomes by 2030

    Bio-IT World | Russia plans to significantly expand its national database of genetic information by 2030 according to a recent decree approved by the Russian government. As part of the plans, the volume of the already existing database will be increased by 35 times and reach 35 petabytes by 2030.

    Aug 7, 2025
  • New Research and Pipeline Updates at Alzheimer’s Conference

    Bio-IT World | The Alzheimer's Association International Conference was held last week in Toronto and researchers and companies gathered to present their progress in the fight to diagnose and treat Alzheimer’s disease. Among the timely new developments: new products from Quanterix; pre-clinical data from AltPep, OncoC4, and NKGen Biotech; pipeline updates from Eisai, Biogen, and Roche; and more.

    Aug 6, 2025